Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression

References

• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
   PubMed Web of Science ®Google Scholar
• Health & Social Care Information Centre [webpage on the Internet]Antidepressants show greatest increase in number of prescription items dispensedNHS Digital2016 [cited June 20, 2018]. Available from: http://content.digital.nhs.uk/article/7159/Antidepressants-show-greatest-increase-in-number-of-prescription-items-dispensedAccessed May 2, 2018
   Google Scholar
• BerlimMTTureckiGDefinition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methodsCan J Psychiatry2007521465417444078
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• ThomasLKesslerDCampbellJPrevalence of treatment-resistant depression in primary care: cross-sectional dataBr J Gen Pract201363617e852e85824351501
   PubMed Web of Science ®Google Scholar
• MauskopfJASimonGEKalsekarANimschCDunayevichECameronANonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorderDepress Anxiety2009261839718833573
   PubMed Web of Science ®Google Scholar
• MrazekDAHornbergerJCAltarCADegtiarIA review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013Psychiatr Serv201465897798724789696
   PubMed Web of Science ®Google Scholar
• MccronePKillaspyHBebbingtonPThe REACT study: cost-effectiveness analysis of assertive community treatment in North LondonPsychiatr Serv200960790891319564220
   PubMedGoogle Scholar
• ThaseMENew medications for treatment-resistant depression: a brief review of recent developmentsCNS Spectr201722S1394829350129
   PubMedGoogle Scholar
• IonescuDFRosenbaumJFAlpertJEPharmacological approaches to the challenge of treatment-resistant depressionDialogues Clin Neurosci201517211112626246787
   PubMed Web of Science ®Google Scholar
• MinelliCBaioGValue of information: a tool to improve research prioritization and reduce wastePLoS Med2015129e100188226418866
   PubMedGoogle Scholar
• ClaxtonKEggingtonSGinnellyLA pilot study of value of information analysis to support research recommendations for the National Institute for Health and Clinical ExcellenceCHE Research Paper 4LondonCentre for Health Economics, University of York2005
   Google Scholar
• CowenPJAndersonIMNew approaches to treating resistant depressionBJPsych Adv2015215315323
   Google Scholar
• CowenPJBacking into the future: pharmacological approaches to the management of resistant depressionPsychol Med201747152569257728838328
   PubMedGoogle Scholar
• EdwardsSJHamiltonVNhereraLTrevorNLithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluationHealth Technol Assess201317541190
   Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry19791344382389444788
   PubMed Web of Science ®Google Scholar
• ThaseMECoryaSAOsuntokunOA randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorderJ Clin Psychiatry200768222423617335320
   PubMed Web of Science ®Google Scholar
• CoryaSAWilliamsonDSangerTMBriggsSDCaseMTollefsonGA randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depressionDepress Anxiety200623636437216710853
   PubMed Web of Science ®Google Scholar
• SheltonRCWilliamsonDJCoryaSAOlanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceJ Clin Psychiatry200566101289129716259543
   PubMed Web of Science ®Google Scholar
• SheltonRCTollefsonGDTohenMA novel augmentation strategy for treating resistant major depressionAm J Psychiatry2001158113113411136647
   PubMed Web of Science ®Google Scholar
• FekaduAWoodersonSCRaneLJMarkopoulouKPoonLCleareAJLong-term impact of residual symptoms in treatment-resistant depressionCan J Psychiatry201156954955721959030
   PubMedGoogle Scholar
• Office for National Statistics [webpage on the Internet]Consumer price inflation time series dataset2017 [cited June 20, 2018]. Available from: https://www.ons.gov.uk/economy/inflationandpriceindices/datasets/consumerpriceindicesAccessed March 1, 2017
   Google Scholar
• McCreaRLSammonCJNazarethIPetersenIInitiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort studyBr J Psychiatry2016209542142627539294
   PubMed Web of Science ®Google Scholar
• Joint Formulary Committee [homepage on the Internet]British National formulary (online)2017 Available from: http://www.medicinescom-plete.comAccessed March 24, 2017
   Google Scholar
• SapinCFantinoBNowickiMLKindPUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHealth Qual Life Outcomes2004212015128456
   PubMedGoogle Scholar
• MalhiGSByrowYIs treatment-resistant depression a useful concept?Evid Based Mental Health201619113
   PubMedGoogle Scholar
• GredenJFThe burden of disease for treatment-resistant depressionJ Clin Psychiatry200162Suppl 162631
   PubMedGoogle Scholar
• NemeroffCBPrevalence and management of treatment-resistant depressionJ Clin Psychiatry200768Suppl 8172517640154
   PubMed Web of Science ®Google Scholar
• McintyreRSFilteauMJMartinLTreatment-resistant depression: definitions, review of the evidence, and algorithmic approachJ Affect Disord20141561724314926
   PubMed Web of Science ®Google Scholar
• ConwayCRGeorgeMSSackeimHAToward an evidence-based, operational definition of treatment-resistant depression: when enough is enoughJAMA Psychiatry201774191027784055
   PubMed Web of Science ®Google Scholar
• KubitzNVossenCPapadimitropoulouKKarabisAThe prevalence and disease burden of treatment-resistant depression – a systematic review of the literatureValue Health2014177A455A456
   PubMedGoogle Scholar
• MeadsCACnossenJSMeherSMethods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modellingHealth Technol Assess2008126iiiiv1270
   Google Scholar
• Department of Health and Social Care [webpage on the Internet]Reference costs 2010-2011201111 [cited June 20, 2018]. Available from: https://www.gov.uk/government/publications/2010-11-reference-costs-publicationAccessed March 27, 2017
   Google Scholar
• National Collaborating Centre for Mental Health (UK)National Institute for Health and Clinical Excellence: Guidance Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary CareLeicester, UKThe British Psychological Society & The Royal College of Psychiatrists2006
   Google Scholar
• CurtisLUnit Costs of Health & Social Care 2011CanterburyPersonal Social Services Research Unit2011
   Google Scholar
• KesslerRCThe costs of depressionPsychiatr Clin North Am201235111422370487
   PubMed Web of Science ®Google Scholar